Business profile & competitive position
Northrop Grumman Corporation operates in the Industrials sector, specifically the Aerospace & Defense industry. Its 10-K describes a leading global aerospace and defense technology company that supplies space systems, military aircraft, missile defense, advanced weapons and long-range fires, mission systems, networking and communications, strategic deterrence systems, and breakthrough technologies such as advanced computing, microelectronics and cyber. Customers are primarily U.S. and international government buyers, principally the U.S. Department of War (DoW) and the intelligence community. The company reports through four operating segments: Aeronautics Systems, Defense Systems, Mission Systems and Space Systems.
The financial signature is informative: a 10.5% net margin and a 26.6% return on equity. A ROE that far exceeds net margin points to solid capital efficiency and the ability to generate shareholder returns without relying purely on wide pricing spreads. In a defense contracting business, this profile lines up with long-cycle program visibility, a heavily booked backlog, and entrenched customer relationships. U.S. government sales accounted for 84% of 2025 total sales, anchoring revenue to large, multi-year procurement decisions rather than discretionary commercial demand.
Financial posture
Northrop Grumman carries a $78.0 billion market capitalization and trades at a P/E ratio of 17.4. Profitability metrics include a 10.5% net margin and a 26.6% ROE. The most unusual reading is the stock's beta of -0.11. A negative beta means the shares have historically moved inversely to the broader equity market, which is uncommon outside of select defensive or idiosyncratically contracted businesses. For a prime defense contractor, that figure can reflect the market's treatment of long-duration government programs as a relative shelter during broad risk-off moves, though beta is a backward-looking statistic and can shift over time.
At a trailing P/E of 17.4, the stock is not priced at a deep discount relative to the broader industrials complex, but neither is it stretched. The combination of 26.6% ROE, a 10.5% net margin and negative beta describes a company whose returns are driven by program execution and capital structure discipline rather than by operating leverage to a cyclical upswing.
Strategic priorities & outlook
The company's 10-K outlines four near-term operational priorities. First, compete and win programs that enable continued growth while performing on commitments and affordably delivering customer capability. Second, leverage investments in advanced technologies, a talented workforce and digital transformation capabilities to meet customer needs today and in the future. Third, execute a talent strategy focused on recruiting and deploying talent, building a future-ready workforce and engaging employees to support long-term growth. Fourth, pursue Net Zero greenhouse gas emissions for Scopes 1 and 2 in operations by 2035, alongside sourcing renewable electricity and reducing water withdrawals and solid waste.
Operationally, the backlog grew to $95.7 billion at December 31, 2025, from $91.5 billion at December 31, 2024, giving the company booked work that exceeds its current $78.0 billion market capitalization. Cost-type and fixed-price contracts each represented approximately 50% of 2025 sales, meaning earnings depend on both cost-pass-through mechanics and disciplined fixed-price execution. The filing also notes that raw-material challenges tied to inflation, geopolitical conflicts and microelectronics shortages have increased costs and lead times but, to date, have not materially impacted the company's ability to perform on contracts.
Macro & geopolitical exposure
As an Aerospace & Defense contractor, Northrop Grumman's macro exposure is dominated by U.S. and allied defense budgets, procurement priorities and congressional appropriations rather than by consumer demand. The industry is heavily regulated, subject to export controls, security classifications, contract audits and cost-accounting standards. Trade policy matters because defense supply chains depend on specialized materials and semiconductors; the August 2026 headlines about rare earth elements illustrate how commodity access and tariffs can ripple through the sector.
Currency exposure is generally limited because most revenue is denominated in U.S. dollars, but international program wins can create translation and sovereign-risk considerations. Supply-chain constraints—particularly microelectronics shortages—can raise costs or extend lead times. The roughly 50/50 split between cost-type and fixed-price contracts means half the sales base carries some margin risk if input costs rise, while the other half is more naturally hedged. Geopolitical tension can raise long-term demand for deterrence, space and missile-defense capabilities, but the timing and funding of specific programs remain political variables.
Recent developments
On August 24, 2026, four headline stories surfaced that frame how the market is currently discussing the stock:
- benzinga.com asked why a $1.55 billion rare-earth move by the Trump administration matters for Lockheed Martin, RTX and Northrop Grumman, tying the company to a broader defense supply-chain theme.
- zacks.com compared LMT and NOC on growth prospects, placing Northrop in a direct peer valuation discussion.
- defenseworld.net reported that Allstate Corp had decreased its position in Northrop Grumman, while also noting that Bank of Nova Scotia holds a $28.76 million stake in the company.
Together these headlines show institutional position changes, peer comparisons and policy-driven supply-chain attention rather than company-specific operational news. They are useful for understanding sentiment context around the ticker.
Earnings behavior & post-earnings drift
Northrop Grumman has beaten the market's real expectation in 7 of the last 8 reported quarters, an 88% beat rate, with an average earnings surprise of 1.1%. The average 5-day price move in the trading sessions after those reports is +1.23%, classified as an upward drift.
The last four quarters illustrate the nuance behind those averages:
- On July 21, 2026, NOC reported EPS of $7.68 against an estimate of $6.82, a 12.6% beat. The stock rose 2.54% the next day and 7.21% over the following five sessions.
- On April 21, 2026, EPS came in at $6.14 versus $6.06 estimated, a 1.3% beat, but the stock still fell 3.52% the next day and 5.45% over five sessions.
- On January 27, 2026, EPS of $7.23 beat the $6.98 estimate by 3.6%, producing a 1.53% next-day gain and a 3.87% five-day gain.
- On October 21, 2025, EPS of $7.67 beat the $6.44 estimate by 19.1%, yet the stock slipped 0.48% the next day and 0.72% over five sessions.
These examples make clear that beating consensus is not the same as a positive price reaction; magnitude, guidance and sector sentiment also matter. The next report is scheduled for October 20, 2026, before the market opens, with a consensus EPS estimate of $7.17. As of the current snapshot, the stock trades at $549.28, with an RSI of 45.8 and a 50-day EMA of $556.69—positioning it modestly below its short-term moving average heading into that report.
Frequently Asked Questions
What does Northrop Grumman's negative beta mean?
The stock's beta is -0.11, which means it has historically moved inversely to the broader equity market. That is unusual, but for a large defense contractor it can reflect the market's tendency to treat long-cycle government revenue as a relative shelter during broad risk-off moves. Beta is backward-looking, so it describes past behavior rather than forecasting future correlation.
Can NOC beat earnings and still fall after the report?
Yes. On April 21, 2026, NOC beat the $6.06 estimate by 1.3% with $6.14 EPS, yet the stock fell 3.52% the next day and 5.45% over five sessions. On October 21, 2025, it beat by 19.1% and still declined 0.48% the next day. Beating the consensus is only one input; guidance, margin mix and sector sentiment also drive the post-earnings price reaction.
What are Northrop Grumman's main strategic priorities?
According to its 10-K, the company aims to compete and win programs while affordably delivering capability; leverage advanced technologies, workforce development and digital transformation; execute a talent strategy for long-term growth; and reach Net Zero greenhouse gas emissions for Scopes 1 and 2 in operations by 2035.
For a deeper dive into how institutional analysts currently weigh Northrop Grumman's backlog quality, contract mix and the upcoming October 20, 2026 earnings report, review the full institutional verdict on the ticker page.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-07-21 | $7.68 | $6.82 | +12.6% | +2.54% | +7.21% |
| 2026-04-21 | $6.14 | $6.06 | +1.3% | -3.52% | -5.45% |
| 2026-01-27 | $7.23 | $6.98 | +3.6% | +1.53% | +3.87% |
| 2025-10-21 | $7.67 | $6.44 | +19.1% | -0.48% | -0.72% |
| 2025-07-22 | $7.11 | $6.92 | +2.7% | - | - |
| 2025-04-22 | $3.32 | $6.24 | -46.8% | - | - |
Previous NOC editions
Get the institutional verdict on NOC
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the NOC verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.